These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [An experimental study on the blood vessel sclerosing therapeutic agents for cavernous hemangiomas].
    Author: Guo J, Wu H.
    Journal: Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Aug; 19(4):256-9. PubMed ID: 12539736.
    Abstract:
    OBJECTIVE: This study was designed to test what are the suitable drugs for sclerotherapy and investigate the formation mechanism of cavernous hemangiomas. METHODS: A total of 84 rabbits were selected for this study, and divided into 6 groups, including one control group and five experimental groups. We selected auricular veins of rabbits as the location of injection. The rabbits of the control were injected with physiological saline, and the rabbits of the experimental groups were injected respectively with various drugs, including 5% sodium morrhuate, 10% alum, pinyungmycin, leurocristine and the combination of pinyungmycin and dexamethasone. Histopathological changes were analyzed after 3, 7, 14, 21, 28, 35 days of sclerotherapy. RESULTS: According to histopathological changes of tissue, 5% sodium morrhuate, 10% alum, and the combination of pinyungmycin and dexamethasone produced better eutherapeutic effects, when comparing with other methods. However, 5% sodium morrhuate caused tissue necrosis of the injection site. CONCLUSION: The combined therapy of pinyungmycin and dexamethasone produced excellent sclerotic effects. Whatever drugs causing serious damage of HVEC may contribute to the therapy for cavernous hemangiomas.
    [Abstract] [Full Text] [Related] [New Search]